Statement of stand-alone Financial Results for the quarter and year ended 31st March, 2014
Rs. lakhs
PARTICULARS
PART I : STATEMENT OF STAND-ALONE
RESULTS
01. Gross Sales / Income from Operations
Less : Excise Duty
Less : Sales Tax
Net Sales / Income from Operations
02. Other Operating Income
03. TOTAL INCOME FROM OPERATIONS
04. EXPENDITURE
a) Cost of materials consumed
b) Purchases of stock-in-trade
c) Changes in inventories of finished goods, work-inprogress and stock-in-trade
d) Employee benefits expense
e) Depreciation and amortization expense
f) Other Expenses
TOTAL EXPENSES
05. Profit / (Loss) from Operations before other income,
finance costs and exceptional items
06. Other Income
07. Finance costs
08. Exceptional Items
09. Profit / (Loss) from ordinary activities before tax
10. Tax expense, including deferred tax
11. Net Profit / Loss (-) from ordinary activities after tax
12. Paid-up Equity Share Capital (each share of Rs. 10/face value)
13. Reserves excluding revaluation reserves as per
Balance Sheet of previous accounting year
14. Earnings per share – Basic and diluted EPS before
and after extraordinary item (Rs.) – non-annualized
PART II : SELECT INFORMATION
15. Public Shareholding:
a) Number of Shares
b) Percentage of Shareholding
16. Promoters and Promoter Group Shareholding
a) Pledged / Encumbered –
b) Non – encumbered – No. of shares
Percentage (as a % of the total shareholding of
promoter and promoter group)
Percentage (as a % of the total share
capital of the company)
Dated at Hyderabad, this, the 29th day of May, 2014.
for and on behalf of the Board of Directors,
NATCO Pharma Limited
THREE MONTHS ENDED
(UN-AUDITED)
31-MAR2014
31-DEC2013
YEAR ENDED (AUDITED)
31-MAR2013
31-MAR2014
31-MAR2013
15090
345
306
14439
884
15323
16347
321
321
15705
1718
17423
13536
435
278
12823
1508
14331
59710
1332
1174
57204
5029
62233
54656
2122
1101
51433
4492
55925
4558
-
4485
-
4774
70
16670
-
18063
558
-187
2512
696
4776
12355
2968
-908
2492
686
5531
12286
5137
-690
2087
536
4688
11465
2866
-1597
9422
2679
19080
46254
15979
-2125
8536
1984
15201
42217
13708
939
614
3293
659
2634
3307
105
877
4365
1123
3242
3307
203
769
2300
1128
1172
3137
1571
3405
14145
3126
11019
3307
1194
2512
1158
11232
3419
7813
3137
7.96
7.96
10.14
10.14
3.74
3.74
69983
34.49
34.49
50621
25.02
24.91
15,365,107
46.46
15,311,593
46.30
13,594,593
43.33
15,365,107
46.46
13,594,593
43.33
17,707,967
100
53.54
17,761,481
100.00
53.70
17,778,481
100.00
56.67
17707967
100
53.54
17,778,481
100.00
56.67
Status of Investor Complaints as at 31st March, 2014
Pending as on 01-01-2014
Received during the quarter
Resolved during the quarter
Pending as on 31-03-2014
Nil
65
65
Nil
V.C. Nannapaneni
Chairman & Managing Director
_____________________________________________________________________________________________________________________________________________
Regd. Office: NATCO House, Road # 2, Banjara Hills, Hyderabad : 500 033.
Statement of stand-alone Assets and Liabilities (Rs. in lakhs)
Particulars
As at
31-Mar-2014
(Audited)
As at
31-Mar-2013
(Audited)
Equity & Liabilities
Shareholders’ Funds
a)
b)
Share Capital
Reserves & Surplus
Sub-total : Shareholders’ funds
Non-current liabilities
3307
69983
73290
3137
50621
53758
a)
b)
c)
d)
9497
4233
69
1063
14862
13713
4112
69
821
18715
a)
b)
c)
d)
9863
9918
9648
41
29470
117622
14774
9638
8830
33
33275
105748
52319
579
9294
8858
12516
322
83888
46565
491
7837
7676
12066
261
74896
32
16197
11584
770
4899
252
33734
81
12832
12646
750
4269
274
30852
117622
105748
Long term borrowings
Deferred tax liabilities (net)
Other long-term liabilities
Long term provisions
Sub-total : Non-current Liabilities
Current Liabilities
Short term borrowings
Trade payables
Other current liabilities
Short-term provisions
Sub-total : Current Liabilities
TOTAL – EQUITY AND LIABILITIES
Assets
Non-current Assets
a)
b)
c)
d)
e)
Fixed Assets
Tangible Assets
Intangible Assets
Capital work-in-progress
Non-current investments
Long term loans and advances
Other non-current assets
Sub-total : Non-current Assets
Current Assets
a)
b)
c)
d)
e)
f)
Current Investments
Inventories
Trade receivables
Cash and cash equivalents
Short term loans and advances
Other current assets
Sub-total : Current Assets
TOTAL – ASSETS
Statement of consolidated Financial Results for the quarter and year ended 31st March, 2014
Rs. lakhs
PARTICULARS
PART I : STATEMENT OF CONSOLIDATED
RESULTS
01. Gross Sales / Income from Operations
Less : Excise Duty
Less : Sales Tax
Net Sales / Income from Operations
02. Other Operating Income
03. TOTAL INCOME FROM OPERATIONS
04. EXPENDITURE
a) Cost of materials consumed
b) Purchases of stock-in-trade
c) Changes in inventories of finished goods,
work-in-progress and stock-in-trade
d) Employee benefits expense
e) Depreciation and amortization expense
f) Other Expenses
TOTAL EXPENSES
05. Profit / (Loss) from Operations before other
income, finance costs and exceptional items
06. Other Income
07. Finance costs
08. Exceptional Item
09. Profit / (Loss) from ordinary activities before
tax
10. Tax expense, including deferred tax
11. Minority Interest
12. Net Profit / Loss (-) from ordinary activities
after tax
13. Paid-up Equity Share Capital (each share of
Rs. 10/- face value)
14. Reserves excluding revaluation reserves as
per Balance Sheet of previous accounting year
PART II : SELECT INFORMATION
15. Earnings per share – Basic and diluted EPS
before and after extraordinary item (Rs.) – nonannualized
16. Public Shareholding:
a) Number of Shares
b) Percentage of Shareholding
16. Promoters and Promoter Group Shareholding
a) Pledged / Encumbered – No. of shares
b) Non – encumbered – No. of shares
Percentage (as a % of the total shareholding
of promoter and promoter group)
Percentage (as a % of the total share
capital of the company)
Dated at Hyderabad, this, the 29th May 2014
for and on behalf of the Board of Directors,
NATCO Pharma Limited
THREE MONTHS ENDED
(UNREVIEWED/UNAUDITED)
31-MAR2014
31-DEC2013
YEAR ENDED
(AUDITED)
31-MAR2013
31-MAR2014
31-MAR2013
18131
345
305
17481
899
18380
19260
321
321
18618
1718
20336
16156
430
278
15448
1283
16731
71406
1380
1182
68844
5045
73889
64954
2122
1101
61731
4322
66053
5003
1439
4970
1729
4794
1586
16010
8889
17757
8714
-167
3079
797
5300
15451
2929
-908
2976
770
6177
15714
4622
-755
2539
625
5143
13932
2799
-1577
11277
3045
21356
59000
14889
-2191
10229
2212
16552
53273
12780
996
742
3183
127
922
3827
186
823
2162
1671
3662
12898
1241
2631
1158
10232
634
147
2402
1082
-243
2988
1321
-291
1132
3087
-463
10274
3644
-599
7187
3307
3307
3137
3307
3137
69280
50217
7.26
7.26
9.34
9.34
3.61
3.61
32.16
32.16
23.01
22.91
15,365,107
46.46
15,311,593
46.30
13,594,593
43.33
15,365,107
46.46
13,594,593
43.33
1,77,07,967
100
53.54
17,761,481
100.00
53.70
17,778,481
100.00
56.67
1,77,07,967
100
53.54
17,778,481
100.00
56.67
Status of Investor Complaints as at 31st March 2014
Pending as on 01-01-2014
Received during the quarter
Resolved during the quarter
Pending as on 31-03-2014
Nil
65
65
Nil
V.C. Nannapaneni
Chairman & Managing Director
____________________________________________________________________________________________________________________________________________________
Regd. Office: NATCO House, Road # 2, Banjara Hills, Hyderabad : 500 033.
Statement of Consolidated Assets and Liabilities (Rs. in lakhs)
Particulars
As at
31-Mar-2014
(Audited)
As at
31-Mar-2013
(Audited)
Equity & Liabilities
Shareholders’ Funds
a)
b)
Share Capital
Reserves & Surplus
Sub-total : Shareholders’ funds
3307
69280
72587
3137
50217
53354
c)
Minority Interest
688
1054
a)
b)
c)
d)
9549
4305
104
1109
15067
13783
4433
69
862
19147
a)
b)
c)
d)
9863
10979
10218
168
31228
119571
14774
10585
9021
107
34487
108042
61274
3200
12377
157
5425
324
82757
55391
2884
10584
154
5720
261
74994
32
18113
11880
1105
5432
252
36814
81
14603
12971
1078
4041
274
33048
119571
108042
Non-current liabilities
Long term borrowings
Deferred tax liabilities (net)
Other long-term liabilities
Long term provisions
Sub-total : Non-current Liabilities
Current Liabilities
Short term borrowings
Trade payables
Other current liabilities
Short-term provisions
Sub-total : Current Liabilities
TOTAL – EQUITY AND LIABILITIES
Assets
Non-current Assets
a)
Fixed Assets
Tangible Assets
Intangible Assets
b) Capital work-in-progress
c)
Non-current investments
d) Long term loans and advances
e) Other non-current assets
Sub-total : Non-current Assets
Current Assets
a)
b)
c)
d)
e)
f)
Current Investments
Inventories
Trade receivables
Cash and cash equivalents
Short term loans and advances
Other current assets
Sub-total : Current Assets
TOTAL – ASSETS
Report of segment wise revenue, Results and Capital Employed under Clause
41 of the Listing Agreement, for the quarter and year ended on 31st March, 2014
Rs. lakhs
THREE MONTHS ENDED
(UNAUDITED / UNREVIEWED)
01. Segment Revenue (Net)
a) Bulk Chemicals
b) Formulations
c) Job Work
d) Unallocated
Total
Less : Inter-segment Revenue
Net Sales / Income from
Operations
02. Segment Results : Profit
(+)/Loss (-) before tax and
interest
a) Bulk Chemicals
b) Formulations
c) Job Work
d) Unallocated
Total
Less : a) Interest
b) Other unallocable
expenditure
c) Unallocable income
Total Profit Before Tax
03. Capital Employed (Segment
Assets – Segment Liabilities)
a) Bulk Chemicals
b) Formulations
c) Job Work
d) Unallocated (Others)
Total
YEAR ENDED
(UNAUDITED /
UNREVIEWED)
31-MAR-2014 31-MAR-2013
31-MAR-2014
31-DEC-2013
31-MAR-2013
4344
10931
237
263
15775
452
15323
5827
11667
343
230
18067
644
17423
6562
7572
219
254
14607
276
14331
22101
38702
1193
2386
64382
2149
62233
23692
29367
944
3244
57247
1322
55925
504
4899
202
197
5802
614
2834
1509
5298
311
204
7322
877
2185
1541
3136
129
223
5029
769
2163
4581
16857
984
2109
24531
3405
8552
5527
12235
728
2915
21405
2512
8855
(939)
3293
(105)
4365
(203)
2300
(1571)
14145
(1194)
11232
39578
38238
165
-4691
73290
40010
36689
236
-3940
72995
36375
32742
94
-15453
53758
39578
38238
165
-4691
73290
36375
32742
94
-15453
53758
The above financial results were reviewed / audited by the Statutory Auditors of the Company, the Audit Committee, and approved by the Board
of Directors at a meeting held at Hyderabad, on Thursday, the 29th May, 2014. In respect of reference relating to non-accounting of minimum
alternate tax credit, in the auditors’ report, the company will review and evaluate the position during the current financial year. Figures for the
previous period(s) have been re-arranged / re-grouped wherever necessary. Figures for the quarter ended on 31st March are the balancing
figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the financial
year. Exceptional item represents amount written off against a pending legal dispute. The stand-alone results are available on the company’s
web-site www.natcopharma.co.in.
Dated at Hyderabad, this, the 29th day of May, 2014.
for and on behalf of the Board of Directors,
NATCO Pharma Limited
V.C. Nannapaneni
Chairman & Managing Director
_______________________________________________________________________________________________________________________________________________
Regd. Office: NATCO House, Road # 2, Banjara Hills, Hyderabad : 500 033.